The Korean stem cell fiasco: shifting the focus.
No one could have failed to have seen the dramatic headlines surrounding Professor Woo Suk Hwang of the Seoul National University. Hwang claimed first place in the race to create patient-specific stem cells from cloned human embryos, only to be discredited shortly afterwards. This article discusses whether such high-profile negative publicity has damaged the regenerative medicine industry in general or whether it has merely shifted the stem cell focus away from South Korea.